COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression.

Source:http://linkedlifedata.com/resource/pubmed/id/17442406

Download in:

View as

General Info

PMID
17442406